Literature DB >> 29782882

Prolonged increase in ser31 tyrosine hydroxylase phosphorylation in substantia nigra following cessation of chronic methamphetamine.

Michael F Salvatore1, Vicki A Nejtek2, Habibeh Khoshbouei3.   

Abstract

Methamphetamine (MA) exposure may increase the risk of motor or cognitive impairments similar to Parkinson's disease (PD) by middle age. Although damage to nigrostriatal or mesoaccumbens dopamine (DA) neurons may occur during or early after MA exposure, overt PD-like symptoms at a younger age may not manifest due to compensatory mechanisms to maintain DA neurotransmission. One possible compensatory mechanism is increased tyrosine hydroxylase (TH) phosphorylation. In the rodent PD 6-OHDA model, nigrostriatal lesion decreases TH protein in both striatum and substantia nigra (SN). However, DA loss in the SN is significantly less than that in the striatum. An increase in ser31 TH phosphorylation in the SN may increase TH activity in response to TH loss. To determine if similar compensatory mechanisms may be engaged in young mice after MA exposure, TH expression, phosphorylation, and DA tissue content were evaluated, along with dopamine transporter expression, 21 days after cessation of MA (24 mg/kg, daily, 14 days). DA tissue content was unaffected by the MA regimen in striatum, nucleus accumbens, SN, or ventral tegmental area (VTA), despite decreased TH protein in SN and VTA. In the SN, but not striatum, ser31 phosphorylation increased over 2-fold. This suggests that increased ser31 TH phosphorylation may be an inherent compensatory mechanism to attenuate DA loss against TH loss, similar to that in an established PD model. These results also indicate the somatodendritic compartments of DA neurons are more vulnerable to TH protein loss than terminal fields following MA exposure.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aging; Dopamine transporter; Methamphetamine; Parkinson’s disease; Phosphorylation; Tyrosine hydroxylase

Mesh:

Substances:

Year:  2018        PMID: 29782882      PMCID: PMC6088751          DOI: 10.1016/j.neuro.2018.05.003

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  80 in total

1.  Cognitive performance of current methamphetamine and cocaine abusers.

Authors:  Sara L Simon; Catherine P Domier; Tiffanie Sim; Kimberly Richardson; Richard A Rawson; Walter Ling
Journal:  J Addict Dis       Date:  2002

2.  Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys.

Authors:  M E Emborg; S Y Ma; E J Mufson; A I Levey; M D Taylor; W D Brown; J E Holden; J H Kordower
Journal:  J Comp Neurol       Date:  1998-11-16       Impact factor: 3.215

3.  ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.

Authors:  Michael F Salvatore
Journal:  J Neurochem       Date:  2014-01-27       Impact factor: 5.372

4.  Depolarization-stimulated catecholamine biosynthesis: involvement of protein kinases and tyrosine hydroxylase phosphorylation sites in situ.

Authors:  M F Salvatore; J C Waymire; J W Haycock
Journal:  J Neurochem       Date:  2001-10       Impact factor: 5.372

5.  Comprehensive profiling of dopamine regulation in substantia nigra and ventral tegmental area.

Authors:  Michael F Salvatore; Brandon S Pruett; Charles Dempsey; Victoria Fields
Journal:  J Vis Exp       Date:  2012-08-10       Impact factor: 1.355

6.  Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.

Authors:  Michael F Salvatore; Jin-Lu Zhang; Delia M Large; Patsy E Wilson; Clelland R Gash; Theresa Currier Thomas; John W Haycock; Guoying Bing; John A Stanford; Don M Gash; Greg A Gerhardt
Journal:  J Neurochem       Date:  2004-07       Impact factor: 5.372

7.  Crystal methamphetamine initiation among street-involved youth.

Authors:  Sasha Uhlmann; Kora Debeck; Annick Simo; Thomas Kerr; Julio S G Montaner; Evan Wood
Journal:  Am J Drug Alcohol Abuse       Date:  2013-11-05       Impact factor: 3.829

8.  Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum.

Authors:  John W Haycock; Laurence Becker; Lee Ang; Yoshiaki Furukawa; Oleh Hornykiewicz; Stephen J Kish
Journal:  J Neurochem       Date:  2003-11       Impact factor: 5.372

Review 9.  The effects of adolescent methamphetamine exposure.

Authors:  Jordan M Buck; Jessica A Siegel
Journal:  Front Neurosci       Date:  2015-04-29       Impact factor: 4.677

10.  Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.

Authors:  Ronald Kuczenski; David S Segal; William P Melega; Goran Lacan; Stanley J McCunney
Journal:  Neuropsychopharmacology       Date:  2009-07-01       Impact factor: 7.853

View more
  1 in total

1.  Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons.

Authors:  Steven M Graves; Sarah E Schwarzschild; Rex A Tai; Yu Chen; D James Surmeier
Journal:  Neurobiol Dis       Date:  2021-05-31       Impact factor: 5.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.